Within the integrin family of cell adhesion receptors, integrins a3b1, a6b1, a6b4 and a7b1 make up a laminin-binding subfamily. The literature is divided on the role of these laminin-binding integrins in metastasis, with different studies indicating either pro-or antimetastatic functions. The opposing roles of the laminin-binding integrins in different settings might derive in part from their unusually robust associations with tetraspanin proteins. Tetraspanins organise integrins into multiprotein complexes within discrete plasma membrane domains termed tetraspanin-enriched microdomains (TEMs). TEM association is crucial to the strikingly rapid cell migration mediated by some of the laminin-binding integrins. However, emerging data suggest that laminin-binding integrins also promote the stability of E-cadherin-based cell -cell junctions, and that tetraspanins are essential for this function as well. Thus, TEM association endows the laminin-binding integrins with both pro-invasive functions (rapid migration) and anti-invasive functions (stable cell junctions), and the composition of TEMs in different cell types might help determine the balance between these opposing activities. Unravelling the tetraspanin control mechanisms that regulate laminin-binding integrins will help to define the settings where inhibiting the function of these integrins would be helpful rather than harmful, and may create opportunities to modulate integrin activity in more sophisticated ways than simple functional blockade.
also present in fibronectin and other matrix proteins; and integrins a1b1, a2b1, a10b1 and a11b1 bind collagens (Refs 1, 2). Several of the collagen-binding integrins can also recognise binding sites in certain laminin isoforms, but for the purpose of this review, laminin-binding integrins refers to the subfamily containing the related a3, a6 and a7 subunits.
The data summarised above paint a complex picture in which many integrins recognise more than one ligand and many ligands contain binding sites for more than one integrin. In addition, they point to a conundrum regarding the molecular basis of functional diversity within specific classes of integrins. Upon ligand binding, different integrins transduce signals that differently influence cell survival, proliferation, cytoskeletal organisation, cell adhesion, and migration. Although a few cytoplasmic effectors have been identified that interact with integrin a subunits, the substantial majority associate directly or indirectly with the cytoplasmic tails of integrin b subunits (Refs 3, 4). Thus, a question that arises for b1 integrins is how so many different heterodimers, each with a common b1 signalling subunit, are able to mediate diverse cellular responses to different ECM proteins.
Here I review how the cell behaviours and signalling pathways mediated by the a3/a6/a7 laminin-binding integrin subfamily differ from those mediated by other integrins, and discuss how these functional and cell biological differences may relate to the unusual ability of the laminin-binding integrins to interact with members of the tetraspanin family of proteins. The a6 subunit is further distinguished by its ability to pair with the b4 (ITGB4) subunit. The unique properties of a6b4 integrin, which associates with tetraspanins as well, are also discussed in the review. Tetraspanin association has significant implications not only for the complex roles the laminin-binding integrins play in metastasis but also for how these integrins might ultimately be targeted in anticancer therapies.
Distinct cell responses mediated by laminin-binding integrins
Early recognition that cellular responses mediated by laminin-binding integrins might be different from those mediated by other integrins came from studies of neurons. Dorsal root ganglion and olfactory epithelial neurons both displayed preferential migration on laminin isoforms compared with other ECM proteins, such as collagens and fibronectin (Refs 5, 6). Moreover, as observed by interference reflectance microscopy, neuronal cells made fewer and smaller close contacts with laminin substrates than they did with fibronectin substrates (Refs 6, 7). The organisation of focal adhesions -the cytoskeletal and signalling complexes that form at sites of integrin adhesion to ECM -also appeared different on laminin: neurons formed prominent focal adhesions on fibronectin, but on laminin they formed smaller and less numerous focal-adhesion-like structures (Ref. 8).
More recently, results similar to those described for neuronal cells have been obtained for tumour and epithelial cells. Lung adenocarcinoma cells, squamous carcinoma cells, and nontransformed keratinocytes all migrated up to fivefold faster on laminin isoforms than on other ECM ligands such as fibronectin or collagen I (COL1A1) (Refs 9, 10, 11, 12). On fibronectin or collagen I, cells formed large actin stress fibres and prominent focal adhesions, while on laminins fewer stress fibres and smaller, more-peripheral focal-adhesion-like structures (sometimes termed 'focal contacts') were observed (Refs 9, 10, 11). Thus, data from both neuronal and tumour cell systems converge on the view that lamininbinding integrins frequently mediate distinct cell behaviours typified by rapid migration, smaller focal complexes, and fewer actin stress fibres.
In principle, the functional differences between laminin-binding integrins and other integrins could result from differences in ligand-binding affinities. However, the dissociation constants (K d s) of activated laminin-binding integrins for different laminin isoforms are in the range of 1-20 nM (Ref. 13), which is similar to the K d of activated a5b1 for fibronectin (10 nM) (Ref. 14) , and the Kds of activated a1b1 and a2b1 for collagen ligands (1-10 nM) (Ref. 15).
Instead, it appears that laminin-binding integrins may signal differently than other integrins. In lung adenocarcinoma cells, adhesion on fibronectin triggered strong activation of the RhoA (RHOA) small GTPase, with little activation of the Rac1 (RAC1) small GTPase (Ref. 9). Conversely a3b1-integrindependent adhesion on laminin-10/11 (termed laminin-511/521 when named according to its composition of a, b and g chains) triggered Rac activation with very little concomitant RhoA activation. In addition, focal adhesion kinase (FAK/PTK2) activation was significantly higher in cells on fibronectin than in cells on laminin-10/11 or laminin-5 (laminin-332), while formation of the trimolecular complex of p130CAS (BCAR1), CrkII (CRK) and DOCK180 (DOCK1), which promotes Rac1 activation and cell migration, was much higher on laminin isoforms than on fibronectin (Ref. 9). Similarly, a3b1-integrin-dependent adhesion of squamous carcinoma cells on laminin-5 resulted in less RhoA activation and enhanced activation of the small GTPase Cdc42 (CDC42) and its effector PAK1, compared with cells adherent on collagen I (Ref. 11).
Collectively, these observations suggest that, compared with other integrin ligands, cellular responses to laminin isoforms involve a different profile of signalling through small GTPases in the Rho family, which control the organisation of the actin cytoskeleton. Signalling through laminin-binding integrins often features minimal activation of RhoA, which controls the formation of actin stress fibres and prominent focal adhesions, and strong activation of Rac1 and Cdc42, which control the formation of lamellipodia and filopodia, respectively. The result is smaller, less numerous focal contacts, and a dynamic actin cytoskeleton oriented towards rapid migration rather than strong substrate adhesion.
With the strikingly rapid migration that laminin isoforms such as laminin-5 can provoke in vitro, an attractive hypothesis is that laminin-binding integrins are poised to be potent mediators of tumour cell motility, migration and invasion during metastasis. Indeed, several studies support the hypothesis that laminin-binding integrins can have prometastatic functions. However, the roles of laminin-binding integrins in metastasis are more complex than such a straightforward hypothesis would suggest, and, depending on the context, the laminin-binding integrins may in fact possess antimetastatic functions. In the following sections, potential pro-and antimetastatic functions of the laminin-binding integrins are discussed, with an emphasis on in vivo experimental results and clinical correlations.
Potential roles of a3b1 integrin in metastasis
Although several studies have identified a positive correlation between tumour cell expression of a3b1 integrin and propensity for metastasis, a roughly equal number of studies have reported negative correlations (Table 1) . Moreover, in some cases, such as breast carcinoma and oral squamous cell carcinomas, both positive and negative correlations have been reported. These conflicting data suggest that the role of a3b1 integrin in metastasis may be highly dependent on context, even within the same general class of tumours. Underlying the potential prometastatic activities of a3b1 integrin might be its ability to promote adhesion, migration and survival in response to its ligands laminin-5 and laminin-10/11, which are present in basement membranes beneath epithelial or endothelial cell layers. The breakdown of adherens junctions triggered by HGF during scattering was found to be a mechanical phenomenon in which the strength of cell -substrate traction forces correlated with the efficiency of adherens junction disruption. The more strongly the cells were able to pull against their substrate, the more able they were to physically pull apart the cell -cell junctions holding them together (Ref. 32). The reduced scattering observed on laminin may therefore be related to the observations discussed above that cell adhesion on laminin results in fewer actin stress fibres and smaller focal contacts than adhesion on other integrin ligands.
Aside from acting as a negative regulator of cell motility in some settings, a3b1 integrin may also have the potential to suppress cell proliferation at secondary tumour sites. In summary, the ability of a3b1 integrin to promote invasion and migration in some tumours may be balanced by its ability to promote 'stay-at-home' cell -substrate or cellcell adhesion or to suppress colonisation at secondary sites in other cases. Whether a3b1's pro-or antimetastatic activities predominate may depend on additional factors such as E-cadherin expression status, passive versus active modes of invasion, or the array of integrin ligands present at primary or secondary tumour sites. As discussed below, the balance between a3b1's opposing roles in metastasis might also be controlled by the complement of a3-associated tetraspanin proteins present in different tumour cell types.
Potential roles of a6b4 and a6b1 integrins in metastasis
In contrast to the a3 integrin subunit, whose expression correlates positively or negatively with metastasis in roughly equal numbers of studies, the expression of the a6 integrin subunit has shown positive correlation in the majority of reports (Table 2 ). There have also been significantly more in vivo studies addressing the functions of a6 integrins in various models of metastatic cell behaviours (Table 3) . Although a6 can pair with either the b1 or b4 subunit, the a6b4 heterodimer has received the most attention by far. Most of the in vivo studies in Table 3 were performed with tumour cell types expressing the a6b4 heterodimer, with the virtually unanimous verdict being that a6b4 integrin has the ability to act as a promoter of tumour progression and metastasis. The unique properties of the b4 integrin cytoplasmic tail may be largely responsible for the a6b4 integrin's prometastatic functions.
The structure and function of integrin b4 has been the subject of several excellent recent reviews (Refs 38, 39, 40), key points of which are summarised briefly here. The b4 cytoplasmic tail, which unlike those of other b integrin subunits is over 1000 amino acids in length, contains interaction domains for several proteins. These b4-interacting proteins include (1) plectin (PLEC1), which links b4 to the keratin cytoskeleton, (2) the hemidesmosomal proteins BP180 (COL17A1) and BP230 (DST), (3) Src (SRC) family kinases, which phosphorylate multiple tyrosine residues in the b4 tail, (iv) the adaptor protein Shc (SHC), which binds to b4 phosphotyrosines and activates the Ras -MAPK (mitogen-activated protein kinase) pathway, and (5) 14-3-3 proteins, which may help promote lateral association of a6b4 with receptor tyrosine kinases. A primary physiological role of a6b4 is to organise epithelial cell hemidesmosomes by binding laminin-5 in the basement membrane and providing mechanical linkage to the keratin intermediate network.
Oncogenic activation of signal transduction pathways can result in tyrosine phosphorylation of the Shc-binding site of b4 as well as protein kinase C (PKC) phosphorylation of key serine residues. Collectively, these modifications result in disassembly of hemidesmosomes and mobilisation of signalling-activated a6b4 integrin. Mobilised a6b4 switches from keratin to actin filament association and may mediate migration and invasion on laminin isoforms. However, many of a6b4's most potent prometastatic functions may involve its ability to act as an amplifier of signalling emanating from activated receptor tyrosine kinases and thereby promote tumour cell survival. These a6b4-mediated prosurvival functions include signalling through phosphoinositide 3-kinase (PI3K) to activate the antiapoptotic serine/ threonine kinase Akt (AKT1) and promote the expression of vascular endothelial growth factor (VEGF). VEGF can both stimulate tumour angiogenesis and exert autocrine effects on the tumour cells themselves. Many of these prometastatic functions of a6b4 may occur independently of laminin binding, reflecting the intrinsic signalling capacity of the b4 cytoplasmic tail. However, a6b4's ability to promote tumourigenesis and progression when transgenically expressed in suprabasal keratinocytes, as well as its ability to support the malignant transformation of human keratinocytes, both depended on binding to laminin-5 (Refs 41, 42).
The cumulative benefits of mobilised a6b4 integrin for tumour progression may explain why this integrin (which plays a crucial role in the maintenance of epithelial structure and thus might be expected a priori to be a metastasis suppressor) is maintained or even elevated in so many carcinomas. Prostate carcinoma is a notable exception. During prostate cancer progression, the a6b4 ligand laminin-5 and the b4 integrin subunit are frequently both downregulated, with a6 switching to the a6b1 form (Ref. 43). The a6b1 integrin binds to laminin-10/11, which is present on the surface of nerves innervating the prostate gland that may serve as a pathway for tumour cell escape from the prostate. Laminin-10/11 is also abundant in the bone matrix, a major site of prostate cancer metastasis, and antibody blockade of a6 integrin can inhibit both bone colonisation and local invasion within the bone (Refs 44, 45).
Despite the data implicating it in malignant progression, a6b4 integrin can display tumoursuppressive activities. In p53 (TP53)-deficient, transformed keratinocytes, genetic deletion of a6b4 enhanced tumour formation, growth, and proliferative index (Ref. 46). However, when the cells were further transformed with oncogenic Ras, a6b4 switched roles and became a promoter of tumour growth. The tumoursuppressive activity of a6b4 observed in the absence of oncogenic Ras did not require ligand engagement, but it was abolished by a point mutation that disrupted the interaction of the b4 cytoplasmic tail with the hemidesmosomal protein plectin (Ref. 46). Thus, the loss of b4 expression that occurs during the progression of certain tumour types may be related to the abrogation of a plectin-dependent antiproliferative signal. In addition, as described above for a3b1 integrin, a6b4 can transduce signals that promote the formation of E-cadherin-based adherens junctions, with the potential to restrain tumour cell motility (Refs 28, 47). 
Potential roles of a7b1 integrin in metastasis

Tetraspanin control mechanisms for laminin-binding integrins Integrin -tetraspanin complexes
Leaving aside the unique signalling properties of the b4 integrin subunit, a question that remains for the other laminin-binding integrins is how they are able to mediate cellular responses that, as described earlier, may differ from those of other b1 integrins. Part of the answer may lie in the targeting of the laminin-binding integrins to distinct microdomains on the plasma membrane defined by the presence of tetraspanin proteins (tetraspanin-enriched microdomains or TEMs; Fig. 1 ).
Tetraspanins are a large family of proteins (33 in mammals) that are characterised by four transmembrane domains, cytoplasmic N-and C-termini, and two extracellular domains (EC1 and EC2 (Fig. 1) . While the majority of TEM-resident proteins identified thus far are transmembrane proteins, some cytoplasmic components have been identified as well (Fig. 1) Figure 1 . Tetraspanin-enriched microdomains. Laminin-binding integrins associate directly with tetraspanin CD151 and are linked to other tetraspanins (such as CD9, CD63, CD81 and CD82) and tetraspanin partner proteins, such as the immunoglobulin superfamily proteins EWI-2 and EWI-F (the EWI proteins). Cytoplasmic effectors associated with tetraspanin-enriched microdomains (TEMs) include type II phosphatidylinositol 4-kinases (PI4KIIs), classical protein kinase C (PKC) isoforms, ezrin -radixin -moesin family proteins (ERMs), and AP adaptor proteins (APs). Key structural features of tetraspanins include large and small extracellular domains (EC2 and EC1, respectively), polar amino acid residues within transmembrane domains 1, 3 and 4, and palmitoylation of intracellular cysteine residues.
with the association of heterotrimeric G-proteincoupled receptors with tetraspanins, heterotrimeric G proteins themselves have also been detected in tetraspanin complexes (Refs 80, 94) (not shown in Fig. 1) .
Numerous studies indicate that the localisation of laminin-binding integrins to TEMs is functionally relevant. Antitetraspanin antibodies, forced expression of tetraspanin mutants, genetic deletion, and RNAi-mediated silencing of tetraspanin expression have all produced examples in which the function of lamininbinding integrins has been compromised (see Refs 82, 95, 96) . Nevertheless, the molecular mechanisms by which tetraspanins regulate integrin function remain murky. The sections below highlight potential tetraspanin control mechanisms for laminin-binding integrins that have emerged from recent studies.
Do tetraspanins regulate integrin -ligand interactions?
Two studies have proposed that tetraspanins may regulate integrin -ligand binding by regulating integrin affinity state. In one study, a soluble a5b1-integrin-ligand mimetic (RGD peptide) was added to parental Chinese hamster ovary (CHO) cells or to a CHO cell subclone overexpressing CD9 (Ref. 97) . The binding of an anti-b1-integrin antibody that recognises a ligand-induced binding site (LIBS) epitope was then assessed by flow cytometry. The apparent upregulation of the LIBS epitope on the CD9-overexpressing cells in response to RGD was modestly higher than that of the parental CHO cells. However, because the CD9 -a5b1 association can be observed only in very mild detergents (Ref. 98) , it may be indirect, raising the question of how CD9 could directly modulate the a5b1 affinity state. An alternative explanation is that CD9 expression could change the clustering or organisation of a5b1 on CHO cells thereby improving the avidity of the bivalent LIBS antibody used in this study.
In the other study, a preparation of a3b1 integrin apparently depleted of associated CD151 was compared with non-CD151-depleted a3b1 upon reconstitution into liposomes (Ref. 99 ). The CD151-depleted a3b1 liposomes bound somewhat less well to laminin-10/11 compared with nondepleted liposomes. The CD151-depleted liposomes also showed reduced binding to wells coated with an anti-b1-integrin-LIBS antibody. Adding back CD151 to the CD151-depleted liposomes restored their binding to laminin-coated wells to normal levels. These results were interpreted as evidence that CD151 might stabilise the activated, ligand-bound conformation of a3b1 integrin, but other interpretations are possible. Given the ability of tetraspanin proteins to selfassociate, increasing CD151 content in liposomes might create clusters or patches containing higher densities of a3b1, enhancing its avidity for physiological or nonphysiological ligands. 
Tetraspanin regulation of integrin trafficking
A variety of studies show that tetraspanins can regulate the trafficking of their partners (reviewed in Refs 90, 95) . In CD151-silenced carcinoma cells migrating on laminin-5, the rate of a3 integrin internalisation was significantly impaired compared with wild-type cells (Ref. 12). Concurrently, persistent protrusions formed at lateral and trailing edges of the migrating tumour cells. Since continuous forward migration depends not only on the formation of new adhesive contacts at the front of the cell but also the disassembly of old adhesive contacts at the rear, one way that tetraspanin association might facilitate the rapid migration mediated by laminin-binding integrins is by promoting efficient integrin internalisation at the lateral or trailing edges of migrating cells. Different complements of tetraspanins might influence integrin trafficking in different cell types. For example, enforced expression of tetraspanin CD82 in Du145 prostate carcinoma cells reduced a6 integrin cell-surface expression, enhanced ligandinduced a6 internalisation, and impaired a6-dependent adhesion and morphogenesis (Ref. 108 ). However, cell-surface a6 was not altered upon CD82 expression in PC-3 prostate carcinoma cells (Ref. 109) , so the effect of CD82 on integrin cell-surface expression is different in different cell types. Mutation of the YXXF motif in the CD151 C-terminal cytoplasmic tail strongly inhibited CD151 internalisation from the cell surface, suggesting that this motif, which might interact with AP adaptor proteins (Fig. 1) , could be important for regulating integrin trafficking (Ref. 110) . However, no difference in the internalisation rate of total cellsurface a6 integrin was observed in cells overexpressing the CD151 YXXF mutant, so the magnitude of its impact on integrin trafficking remains to be determined. In addition, the CD82 YXXF motif appears not to mediate an association with the AP-2 adaptor complex, and may not be required for CD82 internalisation (Ref. 111). Thus, the functionality of the putative YXXF motifs is different for different tetraspanins.
Tetraspanin regulation of integrin signalling
In several independent studies, RNAi-mediated silencing or genetic deletion of tetraspanin CD151 has resulted in impaired signalling through laminin-binding integrins (Refs 76, 77, 78, 112) . Signalling molecules whose activities were reduced in CD151-deficient cells include tyrosine kinases FAK, Src and Lck (LCK), serine/threonine kinases Akt and ERK (MAPK1), and small GTPases Rac1 and Cdc42. Reduced activation of nitric oxide synthase (eNOS, NOS3) and reduced phosphorylation of the focal adhesion scaffold protein paxillin (PXN) have also been reported. In addition, enforced CD82 expression inhibited integrindependent crosstalk with the c-Met (MET) receptor tyrosine kinase and Src signalling through the Src substrates FAK and p130CAS, an adaptor protein important for integrindriven cell motility (Ref. 109 ). CD82 expression might also influence the outright expression level of p130CAS and thus p130CAS-dependent signalling (Ref. 113) .
Collectively, these data indicate that tetraspanin association makes critical contributions to signalling through lamininbinding integrins. However, it remains to be established whether tetraspanin association is simply required for laminin-binding integrins to signal properly or whether tetraspanins endow laminin-binding integrins with some of the unique properties that distinguish them from other integrins. As discussed in preceding expert reviews http://www.expertreviews.org/ in molecular medicine sections, cells adhering on laminins may display less activation of the small GTPase RhoA, fewer actin stress fibres, smaller focal adhesions, and enhanced stability of cell -cell junctions, compared with cells adhering on other integrin ligands. Do tetraspanins contribute to any of these special properties? Support for the possibility that they do comes from a recent study of A431 epidermoid carcinoma cells, which deposit and adhere to their own laminin-5-rich matrix and normally display relatively orderly cell -cell junctions. Near-total RNAimediated silencing of CD151 in A431 cells resulted in significantly elevated RhoA activity, increased actin stress fibres, disorganised adherens junctions, and a more highly dynamic monolayer with a reduced lifespan of cell -cell contacts (Ref. 114) . Treating cells with a cellpermeable RhoA inhibitor or re-expressing wild-type CD151 in the silenced cells reversed these phenotypes, but re-expressing a CD151 mutant with impaired a3b1 integrin association did not. These data suggest that upon loss of CD151 association, a3b1 may lose some of the unique functions that set it apart from the nonlaminin-binding integrins. Supporting these observations, silencing CD151 in HSC5 epidermal carcinoma cells or in embryonic kidney cells also resulted in elevated stress-fibre formation (Refs 103, 115), and forced expression of a CD151 palmitoylation mutant disrupted a3b1 integrin association with other tetraspanins and increased the size of focal adhesions in Rat-1 fibroblasts plated on laminin-5 (Ref. 116) . In addition, an a3 mutant with impaired association with CD151 failed to rescue the disturbed cell -cell junctions observed in a3-null kidney epithelial cells (Ref. 115) .
Figure 2 depicts a working model based on the observations above. Laminin-binding integrins associate with tetraspanin CD151 early in biosynthesis, resulting in delivery of the integrins to TEMs on the cell surface. Tetraspanin association may allow lamininbinding integrins to organise smaller, morepromigratory focal contacts than other integrins. Tetraspanins also contribute to signalling events required for rapid cell migration and may facilitate disassembly and recycling of old adhesive contacts. Collectively, these functions support rapid tumour cell migration, invasion and metastasis. Balancing these promigratory functions, tetraspanin association may also allow the laminin-binding integrins either to generate a Rho-suppressive signal or to avoid activating Rho to the same extent as other integrins, resulting in a low basal level of Rho activity compatible with stable adherens junctions. E-cadherin itself may also participate in these Rho-suppressive functions (Ref. Migration, invasion and metastasis Figure 2 . Consequences of TEM localisation for laminin-binding integrins. Laminin-binding integrins (represented by a3b1) associate with tetraspanin CD151 via a direct protein -protein interaction between the a integrin subunit ectodomain and the CD151 EC2 domain. The integrin-CD151 complex forms early in biosynthesis and is delivered to cell-surface tetraspanin-enriched microdomains (TEMs). TEM localisation may promote a3b1-dependent tumour cell migration on laminin-5 in multiple ways including (1) facilitating the formation of small, promigratory focal contacts, (2) participating in promigratory signalling, and (3) facilitating efficient internalisation of a3b1 at the trailing edge of migrating cells. TEM localisation may also allow a3b1 to collaborate with E-cadherin to reduce the activity of the RhoA small GTPase to a low basal level. Too much RhoA activity can destabilise adherens junctions, which normally function to restrain tumour cell motility. Thus, by keeping RhoA activity low, a3b1-tetraspanin complexes might exert an antimigratory activity that balances a3b1's promigratory functions.
expression-blocking therapeutics will likely depend upon the ability to deliver the therapeutic specifically to tumour cells. Assuming that this technical hurdle can eventually be overcome, the question remains 'under what circumstances would it be advantageous to extinguish laminin-binding integrin function in tumour cells?' Thus far, available data on a6b4 integrin from in vivo models (Table 3) suggest that for tumours bearing signalling-activated, mobilised a6b4 integrin, blocking its function would in most cases be beneficial. There may be exceptions, such as certain gastric carcinomas, in which a6b4 may play a suppressive role (Table 2 ). In addition, analysis of a6b4 in transformed keratinocytes suggests that blocking its function in early-stage tumours might in some cases be counterproductive (Ref. 46). For a3b1 integrin, the situation may be more complex. As the studies summarised in Table 1 and the working model in Figure 2 both emphasise, a3b1's function in tumour progression is likely to be highly dependent on context. For example, in situations where a3b1 is making a strong contribution to the maintenance of stable cellcell junctions, blocking its function might result in a more invasive phenotype rather than reduced invasion. Thus, the role of a3b1 may depend upon factors such as E-cadherin expression status or the complement of tetraspanin proteins present in specific tumours. For a7b1 integrin, the relatively limited data available indicate that it plays a tumour-suppressive role in multiple tumour cell types (Ref. 52 ).
An alternative to blocking or silencing lamininbinding integrins would be to modify their function. Thus far, no a-integrin-subunitspecific activating antibodies have been reported; however, an antimetastatic a6 integrin antibody that inhibits regulated ectodomain cleavage of the a6 subunit (but not a6-dependent adhesion) has recently been described (Ref. 44) . In addition, an anti-a3-integrin antibody that does not block adhesion has been reported to block keratinocyte migration on laminin-5 (Ref. 124) . It might be beneficial to re-evaluate the activities of the wealth of available anti-integrin antibodies, in light of the more sophisticated knowledge of integrin function that has accumulated since many of these reagents were first generated. Features associated with this article Figures  Figure 1 . Tetraspanin-enriched microdomains. Figure 2 . Consequences of TEM localisation for laminin-binding integrins. Tables  Table 1 . Clinical or in vivo experimental studies reporting correlations between a3 integrin expression and metastasis.
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